Touchstone
Last syncNov 1, 2026, 6:55 PM ET

MSA

Msa Safety Inc Health Care Orthopedic, Prosthetic & Surgical Appliances & Supplies Russell 3000
$178.57Close $6.9BMarket cap $151.64 – $201.3552-week range Nov 2, 2026Next report · after the close

Highlights

Strengths

  • Earnings growing EPS +40% year on year, faster than the quarter before (+19 pts)

Cautions

  • Not in an uptrend 4 of 8 trend conditions
  • Lagging the market RS 44 · weaker than 56% of stocks over 12 months
  • Results soon Nov 2, 2026, in 1 day

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Jul 31, 2026
Off 12-month high 11%
1wk down 2.0% price change
1mo up 0.4% price change
12-month return up 15% market up 11% · its own down 4%
F-score 6 / 9 Mixed
Altman Z 5.85 Low risk
P/E 24.9× price / earnings
PEG — P/E / EPS growth
P/B 5.1× price / book
Earnings yield up 5.1% EBIT / enterprise value
Cheaper than 54% of the market · around average
Revenue growth up 4% year on year
EPS growth up 40% latest quarter · +19 pts
Sales growth up 6% latest quarter · -4 pts
ROE up 22% return on equity
Free cash margin up 16% $295.4M FCF
D/E 0.42 long-term debt / equity
Net debt / EBITDA 0.9×
Interest cover —EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • took on more long-term debt
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profits backed by cash
  • short-term liquidity improved
  • no new shares issued
  • assets working harder

Trade setup

ATR% 2.1% $3.74 a day · 2×ATR $171.09
RS 44 / 99 vs the universe
Trend 4 / 8 trend template
Relative volume 1.7× vs 50-day average
Up/down volume 0.88 50 sessions
Implied move — no option chain · report Nov 2, 2026
Trend template · 4 of 8
  • Price above the 150 and 200-day averages: passes
  • 150-day average above the 200-day: fails
  • 200-day average rising for a month: passes
  • 50-day average above the 150 and 200-day: passes
  • Price above the 50-day average: fails
  • At least 30% above the 52-week low: fails
  • Within 25% of the 52-week high: passes
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Gross margin narrowing Gross margin fell from 47.6% to 46.5%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Jul 30, 2026

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.9B +4% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.3B FY2021 · $1.4B FY2022 · $1.5B FY2023 · $1.8B FY2024 · $1.8B FY2025 · $1.9B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $278.9M -2% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $124.1M FY2021 · $21.3M FY2022 · $179.6M FY2023 · $58.6M FY2024 · $285.0M FY2025 · $278.9M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $295.4M +22% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $157.7M FY2021 · $155.3M FY2022 · $114.9M FY2023 · $50.1M FY2024 · $242.2M FY2025 · $295.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 46%
  • Net 15%
  • Free cash 16%
0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 44% · Net 9% · Free cash 12% FY2021 · Gross 44% · Net 2% · Free cash 11% FY2022 · Gross 44% · Net 12% · Free cash 8% FY2023 · Gross 48% · Net 3% · Free cash 3% FY2024 · Gross 48% · Net 16% · Free cash 13% FY2025 · Gross 46% · Net 15% · Free cash 16%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $407.6M net debt
  • Cash
  • Long-term debt
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $160.7M · Long-term debt $287.2M FY2021 · Cash $140.9M · Long-term debt $597.7M FY2022 · Cash $162.9M · Long-term debt $565.4M FY2023 · Cash $146.4M · Long-term debt $575.2M FY2024 · Cash $164.6M · Long-term debt $481.6M FY2025 · Cash $165.1M · Long-term debt $572.7M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 38.91m -0.4% since FY2020
39.32m 38.91m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 39.07m FY2021 · 39.28m FY2022 · 39.21m FY2023 · 39.32m FY2024 · 39.26m FY2025 · 38.91m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.3B $1.4B $1.5B $1.8B $1.8B $1.9B
Gross margin 44% 44% 44% 48% 48% 46%
Operating income $171.9M $22.8M $239.1M $231.3M $389.2M $371.8M
Net income $124.1M $21.3M $179.6M $58.6M $285.0M $278.9M
Net margin 9% 2% 12% 3% 16% 15%
Earnings per share $3.16 $0.54 $4.56 $1.48 $7.21 $7.09
Free cash flow $157.7M $155.3M $114.9M $50.1M $242.2M $295.4M
Free cash margin 12% 11% 8% 3% 13% 16%
Cash $160.7M $140.9M $162.9M $146.4M $164.6M $165.1M
Long-term debt $287.2M $597.7M $565.4M $575.2M $481.6M $572.7M
Shareholders' equity $839.2M $834.4M $923.7M $966.8M $1.1B $1.4B
Shares outstanding 39.07m 39.28m 39.21m 39.32m 39.26m 38.91m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Jul 31, 2026 Quarterly ↗ Jun 30, 2026 31d
May 5, 2026 Quarterly ↗ Mar 31, 2026 35d
Feb 12, 2026 Annual ↗ Dec 31, 2025 43d
Oct 29, 2025 Quarterly ↗ Sep 30, 2025 29d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 1, 2025 Quarterly ↗ Mar 31, 2025 31d
Feb 14, 2025 Annual ↗ Dec 31, 2024 45d
Oct 24, 2024 Quarterly ↗ Sep 30, 2024 24d
Jul 25, 2024 Quarterly ↗ Jun 30, 2024 25d
Apr 30, 2024 Quarterly ↗ Mar 31, 2024 30d
Feb 16, 2024 Annual ↗ Dec 31, 2023 47d
Oct 25, 2023 Quarterly ↗ Sep 30, 2023 25d

Current reports

FiledDisclosed
Jul 30, 2026 Results ↗
Jul 21, 2026 Director or officer change ↗
Jul 9, 2026 Other events ↗
May 8, 2026 Shareholder vote ↗
May 5, 2026 Material agreement · Regulation FD ↗
May 4, 2026 Results ↗
Feb 26, 2026 Other events ↗
Feb 11, 2026 Results ↗
Dec 23, 2025 Director or officer change ↗
Oct 28, 2025 Results ↗
Aug 13, 2025 Director or officer change ↗
Aug 4, 2025 Results ↗